ID   SYUA_RAT                Reviewed;         140 AA.
AC   P37377; P37378; Q53YM9;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   02-OCT-2024, entry version 187.
DE   RecName: Full=Alpha-synuclein;
GN   Name=Snca;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=1661825; DOI=10.1016/0169-328x(91)90043-w;
RA   Maroteaux L., Scheller R.H.;
RT   "The rat brain synucleins; family of proteins transiently associated with
RT   neuronal membrane.";
RL   Brain Res. Mol. Brain Res. 11:335-343(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SYN2), AND TISSUE SPECIFICITY.
RX   PubMed=3411354; DOI=10.1523/jneurosci.08-08-02804.1988;
RA   Maroteaux L., Campanelli J.T., Scheller R.H.;
RT   "Synuclein: a neuron-specific protein localized to the nucleus and
RT   presynaptic nerve terminal.";
RL   J. Neurosci. 8:2804-2815(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SYN1).
RX   PubMed=10582622; DOI=10.1046/j.1471-4159.1999.0732586.x;
RA   Kholodilov N.G., Neystat M., Oo T.F., Lo S.E., Larsen K.E., Sulzer D.,
RA   Burke R.E.;
RT   "Increased expression of rat synuclein in the substantia nigra pars
RT   compacta identified by mRNA differential display in a model of
RT   developmental target injury.";
RL   J. Neurochem. 73:2586-2599(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SYN1).
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=12665621; DOI=10.1073/pnas.0737182100;
RA   Liang T., Spence J., Liu L., Strother W.N., Chang H.W., Ellison J.A.,
RA   Lumeng L., Li T.K., Foroud T., Carr L.G.;
RT   "Alpha-synuclein maps to a quantitative trait locus for alcohol preference
RT   and is differentially expressed in alcohol-preferring and - nonpreferring
RT   rats.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:4690-4695(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SYN1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 33-97, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [7]
RP   UBIQUITINATION, AND INTERACTION WITH UCHL1.
RX   PubMed=12408865; DOI=10.1016/s0092-8674(02)01012-7;
RA   Liu Y., Fallon L., Lashuel H.A., Liu Z., Lansbury P.T. Jr.;
RT   "The UCH-L1 gene encodes two opposing enzymatic activities that affect
RT   alpha-synuclein degradation and Parkinson's disease susceptibility.";
RL   Cell 111:209-218(2002).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Neuronal protein that plays several roles in synaptic
CC       activity such as regulation of synaptic vesicle trafficking and
CC       subsequent neurotransmitter release (By similarity). Participates as a
CC       monomer in synaptic vesicle exocytosis by enhancing vesicle priming,
CC       fusion and dilation of exocytotic fusion pores (By similarity).
CC       Mechanistically, acts by increasing local Ca(2+) release from
CC       microdomains which is essential for the enhancement of ATP-induced
CC       exocytosis (By similarity). Acts also as a molecular chaperone in its
CC       multimeric membrane-bound state, assisting in the folding of synaptic
CC       fusion components called SNAREs (Soluble NSF Attachment Protein
CC       REceptors) at presynaptic plasma membrane in conjunction with cysteine
CC       string protein-alpha/DNAJC5 (By similarity). This chaperone activity is
CC       important to sustain normal SNARE-complex assembly during aging (By
CC       similarity). Also plays a role in the regulation of the dopamine
CC       neurotransmission by associating with the dopamine transporter (DAT1)
CC       and thereby modulating its activity (By similarity).
CC       {ECO:0000250|UniProtKB:P37840}.
CC   -!- SUBUNIT: Soluble monomer. Homotetramer. A dynamic intracellular
CC       population of tetramers and monomers coexists normally and the tetramer
CC       plays an essential role in maintaining homeostasis (By similarity).
CC       Interacts with UCHL1 (PubMed:12408865). Interacts with phospholipase D
CC       and histones. Interacts (via N-terminus) with synphilin-1/SNCAIP; this
CC       interaction promotes formation of SNCA inclusions in the cytoplasm.
CC       Interacts with CALM1. Interacts with STXBP1; this interaction controls
CC       SNCA self-replicating aggregation. Interacts with SNARE components
CC       VAMP2 and SNAP25; these interactions allows SNARE complex assembly and
CC       integrity (By similarity). Interacts with RPH3A and RAB3A (By
CC       similarity). Interacts with SERF1A; this interaction promotes the
CC       aggregation of SNCA (By similarity). Interacts with SEPTIN4 (By
CC       similarity). {ECO:0000250|UniProtKB:O55042,
CC       ECO:0000250|UniProtKB:P37840, ECO:0000269|PubMed:12408865}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P37840}.
CC       Membrane {ECO:0000250|UniProtKB:P37840}. Nucleus
CC       {ECO:0000250|UniProtKB:P37840}. Synapse {ECO:0000250|UniProtKB:P37840}.
CC       Secreted {ECO:0000250|UniProtKB:P37840}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:O55042}. Note=Membrane-bound in dopaminergic
CC       neurons (By similarity). Expressed and colocalized with SEPTIN4 in
CC       dopaminergic axon terminals, especially at the varicosities (By
CC       similarity). {ECO:0000250|UniProtKB:O55042,
CC       ECO:0000250|UniProtKB:P37840}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Syn1;
CC         IsoId=P37377-1; Sequence=Displayed;
CC       Name=Syn2;
CC         IsoId=P37377-2; Sequence=VSP_006367;
CC       Name=Syn3;
CC         IsoId=P37377-3; Sequence=VSP_006365, VSP_006366;
CC   -!- TISSUE SPECIFICITY: Found only in brain (hippocampus, brainstem and
CC       cortex). Specifically expressed in neuronal cell bodies and synapses.
CC       {ECO:0000269|PubMed:3411354}.
CC   -!- PTM: Phosphorylated, predominantly on serine residues. Phosphorylated
CC       on Tyr-125 upon osmotic stress. {ECO:0000250|UniProtKB:P37840}.
CC   -!- PTM: Ubiquitinated. The predominant conjugate is the diubiquitinated
CC       form. {ECO:0000269|PubMed:12408865}.
CC   -!- PTM: Acetylation at Met-1 seems to be important for proper folding and
CC       native oligomeric structure. {ECO:0000250|UniProtKB:P37840}.
CC   -!- SIMILARITY: Belongs to the synuclein family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S73007; AAB20688.1; -; mRNA.
DR   EMBL; S73008; AAB20689.1; -; mRNA.
DR   EMBL; S73009; AAB20690.1; -; mRNA.
DR   EMBL; AF007758; AAC16026.1; -; mRNA.
DR   EMBL; AY550005; AAS55694.1; -; mRNA.
DR   EMBL; AY550006; AAS55695.1; -; mRNA.
DR   EMBL; BC087682; AAH87682.1; -; mRNA.
DR   PIR; B43959; B43959.
DR   RefSeq; NP_062042.1; NM_019169.2. [P37377-1]
DR   AlphaFoldDB; P37377; -.
DR   BMRB; P37377; -.
DR   BioGRID; 247897; 82.
DR   IntAct; P37377; 3.
DR   STRING; 10116.ENSRNOP00000030609; -.
DR   GlyGen; P37377; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P37377; -.
DR   PhosphoSitePlus; P37377; -.
DR   PaxDb; 10116-ENSRNOP00000040281; -.
DR   PeptideAtlas; P37377; -.
DR   ABCD; P37377; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000039247.5; ENSRNOP00000030609.2; ENSRNOG00000008656.9. [P37377-1]
DR   Ensembl; ENSRNOT00000110072.1; ENSRNOP00000081453.1; ENSRNOG00000008656.9. [P37377-2]
DR   Ensembl; ENSRNOT00055019533; ENSRNOP00055015754; ENSRNOG00055011495. [P37377-1]
DR   Ensembl; ENSRNOT00060039060; ENSRNOP00060032295; ENSRNOG00060022503. [P37377-1]
DR   Ensembl; ENSRNOT00065019019; ENSRNOP00065014544; ENSRNOG00065011697. [P37377-1]
DR   GeneID; 29219; -.
DR   KEGG; rno:29219; -.
DR   UCSC; RGD:3729; rat. [P37377-1]
DR   AGR; RGD:3729; -.
DR   CTD; 6622; -.
DR   RGD; 3729; Snca.
DR   GeneTree; ENSGT00950000183175; -.
DR   HOGENOM; CLU_129378_1_0_1; -.
DR   InParanoid; P37377; -.
DR   OMA; TXSEEGA; -.
DR   OrthoDB; 5321875at2759; -.
DR   PhylomeDB; P37377; -.
DR   TreeFam; TF332776; -.
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   PRO; PR:P37377; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000008656; Expressed in frontal cortex and 18 other cell types or tissues.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:RGD.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0016234; C:inclusion body; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:RGD.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005640; C:nuclear outer membrane; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0031092; C:platelet alpha granule membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0098793; C:presynapse; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0005840; C:ribosome; IDA:RGD.
DR   GO; GO:0099512; C:supramolecular fiber; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0003779; F:actin binding; ISO:RGD.
DR   GO; GO:0043014; F:alpha-tubulin binding; ISO:RGD.
DR   GO; GO:0050544; F:arachidonic acid binding; ISO:RGD.
DR   GO; GO:0048487; F:beta-tubulin binding; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:1903136; F:cuprous ion binding; ISO:RGD.
DR   GO; GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; ISO:RGD.
DR   GO; GO:0070840; F:dynein complex binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0008198; F:ferrous iron binding; ISO:RGD.
DR   GO; GO:0042393; F:histone binding; ISO:RGD.
DR   GO; GO:0030544; F:Hsp70 protein binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0019894; F:kinesin binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; ISO:RGD.
DR   GO; GO:0000287; F:magnesium ion binding; ISO:RGD.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0016491; F:oxidoreductase activity; ISO:RGD.
DR   GO; GO:0043274; F:phospholipase binding; IPI:RGD.
DR   GO; GO:0005543; F:phospholipid binding; IDA:RGD.
DR   GO; GO:0051219; F:phosphoprotein binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0000149; F:SNARE binding; ISO:RGD.
DR   GO; GO:0048156; F:tau protein binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISO:RGD.
DR   GO; GO:1990000; P:amyloid fibril formation; ISO:RGD.
DR   GO; GO:0048148; P:behavioral response to cocaine; IMP:RGD.
DR   GO; GO:0071280; P:cellular response to copper ion; ISO:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0042416; P:dopamine biosynthetic process; ISO:RGD.
DR   GO; GO:0042417; P:dopamine metabolic process; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0006631; P:fatty acid metabolic process; ISO:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0061024; P:membrane organization; ISO:RGD.
DR   GO; GO:0001774; P:microglial cell activation; ISO:RGD.
DR   GO; GO:0042775; P:mitochondrial ATP synthesis coupled electron transport; ISO:RGD.
DR   GO; GO:0007006; P:mitochondrial membrane organization; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1904715; P:negative regulation of chaperone-mediated autophagy; ISO:RGD.
DR   GO; GO:0045963; P:negative regulation of dopamine metabolic process; IMP:BHF-UCL.
DR   GO; GO:0051585; P:negative regulation of dopamine uptake involved in synaptic transmission; ISO:RGD.
DR   GO; GO:0045920; P:negative regulation of exocytosis; ISO:RGD.
DR   GO; GO:0031115; P:negative regulation of microtubule polymerization; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0051622; P:negative regulation of norepinephrine uptake; ISO:RGD.
DR   GO; GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0051612; P:negative regulation of serotonin uptake; ISO:RGD.
DR   GO; GO:0070495; P:negative regulation of thrombin-activated receptor signaling pathway; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0006638; P:neutral lipid metabolic process; ISO:RGD.
DR   GO; GO:0006644; P:phospholipid metabolic process; ISO:RGD.
DR   GO; GO:0045807; P:positive regulation of endocytosis; ISO:RGD.
DR   GO; GO:0045921; P:positive regulation of exocytosis; ISO:RGD.
DR   GO; GO:1903285; P:positive regulation of hydrogen peroxide catabolic process; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0060732; P:positive regulation of inositol phosphate biosynthetic process; ISO:RGD.
DR   GO; GO:0001956; P:positive regulation of neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:1904377; P:positive regulation of protein localization to cell periphery; ISO:RGD.
DR   GO; GO:0001921; P:positive regulation of receptor recycling; ISO:RGD.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:0035543; P:positive regulation of SNARE complex assembly; ISO:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; ISO:RGD.
DR   GO; GO:0051259; P:protein complex oligomerization; ISO:RGD.
DR   GO; GO:0031648; P:protein destabilization; ISO:RGD.
DR   GO; GO:0051262; P:protein tetramerization; ISO:RGD.
DR   GO; GO:0031623; P:receptor internalization; ISO:RGD.
DR   GO; GO:0050812; P:regulation of acyl-CoA biosynthetic process; ISO:RGD.
DR   GO; GO:0014059; P:regulation of dopamine secretion; ISO:RGD.
DR   GO; GO:0014048; P:regulation of glutamate secretion; ISO:RGD.
DR   GO; GO:0040012; P:regulation of locomotion; ISO:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0043030; P:regulation of macrophage activation; ISO:RGD.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0051621; P:regulation of norepinephrine uptake; ISO:RGD.
DR   GO; GO:1905606; P:regulation of presynapse assembly; ISO:RGD.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:1904307; P:response to desipramine; IEP:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; ISO:RGD.
DR   GO; GO:0010040; P:response to iron(II) ion; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0032026; P:response to magnesium ion; ISO:RGD.
DR   GO; GO:0034341; P:response to type II interferon; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0035493; P:SNARE complex assembly; ISO:RGD.
DR   GO; GO:0050808; P:synapse organization; ISO:RGD.
DR   GO; GO:0001963; P:synaptic transmission, dopaminergic; ISO:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISO:RGD.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; ISO:RGD.
DR   GO; GO:0016082; P:synaptic vesicle priming; ISO:RGD.
DR   GO; GO:0048489; P:synaptic vesicle transport; ISO:RGD.
DR   Gene3D; 1.10.287.700; Helix hairpin bin; 1.
DR   InterPro; IPR001058; Synuclein.
DR   InterPro; IPR002460; Synuclein_alpha.
DR   PANTHER; PTHR13820:SF5; ALPHA-SYNUCLEIN; 1.
DR   PANTHER; PTHR13820; SYNUCLEIN; 1.
DR   Pfam; PF01387; Synuclein; 1.
DR   PRINTS; PR01212; ASYNUCLEIN.
DR   PRINTS; PR01211; SYNUCLEIN.
DR   SUPFAM; SSF118375; Synuclein; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell projection; Copper; Cytoplasm;
KW   Direct protein sequencing; Membrane; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Secreted; Synapse;
KW   Ubl conjugation.
FT   CHAIN           1..140
FT                   /note="Alpha-synuclein"
FT                   /id="PRO_0000184031"
FT   REPEAT          20..30
FT                   /note="1"
FT   REPEAT          31..41
FT                   /note="2"
FT   REPEAT          42..56
FT                   /note="3; approximate"
FT   REPEAT          57..67
FT                   /note="4"
FT   REGION          20..67
FT                   /note="4 X 11 AA tandem repeats of [EGS]-K-T-K-[EQ]-[GQ]-V-
FT                   X(4)"
FT   REGION          99..140
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          111..140
FT                   /note="Interaction with SERF1A"
FT                   /evidence="ECO:0000250|UniProtKB:P37840"
FT   BINDING         2
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000250"
FT   BINDING         50
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P37840"
FT   MOD_RES         125
FT                   /note="Phosphotyrosine; by FYN"
FT                   /evidence="ECO:0000250|UniProtKB:P37840"
FT   MOD_RES         129
FT                   /note="Phosphoserine; by PLK2"
FT                   /evidence="ECO:0000250|UniProtKB:P37840"
FT   VAR_SEQ         42
FT                   /note="S -> R (in isoform Syn3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006365"
FT   VAR_SEQ         43..140
FT                   /note="Missing (in isoform Syn3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006366"
FT   VAR_SEQ         104..140
FT                   /note="EEGYPQEGILEDMPVDPSSEAYEMPSEEGYQDYEPEA -> YPMGECTNHPP
FT                   RLIALRVKSRYREHSWRPRKQLSLACVVMDPFLPT (in isoform Syn2)"
FT                   /evidence="ECO:0000303|PubMed:3411354"
FT                   /id="VSP_006367"
SQ   SEQUENCE   140 AA;  14515 MW;  1FFD19CD3B9E636C CRC64;
     MDVFMKGLSK AKEGVVAAAE KTKQGVAEAA GKTKEGVLYV GSKTKEGVVH GVTTVAEKTK
     EQVTNVGGAV VTGVTAVAQK TVEGAGNIAA ATGFVKKDQM GKGEEGYPQE GILEDMPVDP
     SSEAYEMPSE EGYQDYEPEA
//
